{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:45:35Z","timestamp":1792590335912,"version":"4.5.0"},"reference-count":41,"publisher":"MyJove Corporation","issue":"229","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70371","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:03:16Z","timestamp":1773270196000},"source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Efficacy of 308-nm Excimer Laser Combined with Matrine in Vitiligo by Modulation of Serum Immunoglobulins and Inflammatory Cytokines"],"prefix":"10.3791","author":[{"given":"Lihui","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaci.2025.06.002","type":"journal-article","article-title":"Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin","volume":"156","author":"Brunner","year":"2025","unstructured":"Brunner, P. M. et al. Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin. J Allergy Clin Immunol. 156 (4), 993-1007 (2025).","journal-title":"J Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1197630","DOI":"10.3389\/fimmu.2023.1197630","type":"journal-article","article-title":"Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy","volume":"14","author":"Carbone","year":"2023","unstructured":"Carbone, M. L. et al. Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy. Front Immunol. 14, 1197630 (2023).","journal-title":"Front Immunol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/ijd.17959","type":"journal-article","article-title":"Regulatory T cell dysregulation in vitiligo: A meta-analysis and systematic review of immune mechanisms and therapeutic perspectives","volume":"64","author":"Lerner","year":"2025","unstructured":"Lerner, G. et al. Regulatory T cell dysregulation in vitiligo: A meta-analysis and systematic review of immune mechanisms and therapeutic perspectives. Int J Dermatol. 64 (12), 2247-2256 (2025).","journal-title":"Int J Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/CCID.S451080","type":"journal-article","article-title":"Identification of shared biomarkers and immune infiltration signatures between vitiligo and Hashimoto's thyroiditis","volume":"17","author":"Lu","year":"2024","unstructured":"Lu, J. et al. Identification of shared biomarkers and immune infiltration signatures between vitiligo and Hashimoto's thyroiditis. Clin Cosmet Investig Dermatol. 17, 311-327 (2024).","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"2468692","DOI":"10.1080\/03014460.2025.2468692","type":"journal-article","article-title":"Unravelling the molecular mechanisms and immune landscape of vitiligo: A comprehensive bioinformatics study on melanogenesis-related genes","volume":"52","author":"Ma","year":"2025","unstructured":"Ma, B., Wang, X. Unravelling the molecular mechanisms and immune landscape of vitiligo: A comprehensive bioinformatics study on melanogenesis-related genes. Ann Hum Biol. 52 (1), 2468692 (2025).","journal-title":"Ann Hum Biol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2025.01.004","type":"journal-article","article-title":"Genetics and epigenetics in vitiligo","volume":"117","author":"Okamura","year":"2025","unstructured":"Okamura, K., Suzuki, T. Genetics and epigenetics in vitiligo. J Dermatol Sci. 117 (3), 45-51 (2025).","journal-title":"J Dermatol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/CCID.S496781","type":"journal-article","article-title":"Bioinformatics analysis of oxidative stress-related genes and immune infiltration patterns in vitiligo","volume":"18","author":"Yang","year":"2025","unstructured":"Yang, M., Wang, H., Zhang, R. Bioinformatics analysis of oxidative stress-related genes and immune infiltration patterns in vitiligo. Clin Cosmet Investig Dermatol. 18, 475-489 (2025).","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ijd.17148","type":"journal-article","article-title":"Vitiligo and psychological stress: A hypothesis integrating the neuroendocrine and immune systems in melanocyte destruction","volume":"63","author":"Al Abadie","year":"2024","unstructured":"Al Abadie, M. S., Chaiyabutr, C., Patel, K. X., Gawkrodger, D. J. Vitiligo and psychological stress: A hypothesis integrating the neuroendocrine and immune systems in melanocyte destruction. Int J Dermatol. 63 (7), 841-843 (2024).","journal-title":"Int J Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2147\/CCID.S488746","type":"journal-article","article-title":"From phenotype to molecules: Unveiling the genetic and immunological bridges between autoimmune diseases and vitiligo","volume":"17","author":"Hu","year":"2024","unstructured":"Hu, Y., Wang, S. B., Wang, K., He, M. J. From phenotype to molecules: Unveiling the genetic and immunological bridges between autoimmune diseases and vitiligo. Clin Cosmet Investig Dermatol. 17, 2475-2486 (2024).","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00011-024-01900-w","type":"journal-article","article-title":"The role of regulatory T cells in vitiligo and therapeutic advances: A mini-review","volume":"73","author":"Jin","year":"2024","unstructured":"Jin, S. et al. The role of regulatory T cells in vitiligo and therapeutic advances: A mini-review. Inflamm Res. 73 (8), 1311-1332 (2024).","journal-title":"Inflamm Res"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"e13868","DOI":"10.1111\/srt.13868","type":"journal-article","article-title":"The relationship between psoriasis and vitiligo: From a comprehensive study","volume":"30","author":"Li","year":"2024","unstructured":"Li, J. et al. The relationship between psoriasis and vitiligo: From a comprehensive study. Skin Res Technol. 30 (7), e13868 (2024).","journal-title":"Skin Res Technol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000528180","type":"journal-article","article-title":"Prevalence of vitiligo among children and adolescents in the United States","volume":"239","author":"Patel","year":"2023","unstructured":"Patel, R. et al. Prevalence of vitiligo among children and adolescents in the United States. Dermatology. 239 (2), 227-234 (2023).","journal-title":"Dermatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1099108","DOI":"10.3389\/fonc.2022.1099108","type":"journal-article","article-title":"Case report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data","volume":"12","author":"Rao","year":"2022","unstructured":"Rao, H. et al. Case report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data. Front Oncol. 12, 1099108 (2022).","journal-title":"Front Oncol"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"e70001","DOI":"10.1111\/srt.70001","type":"journal-article","article-title":"Co-regulatory mechanisms and potential markers of oxidative stress-related genes in vitiligo and alopecia areata","volume":"30","author":"Sun","year":"2024","unstructured":"Sun, C., Ding, H., Zhang, L., Wang, J., Su, M. Co-regulatory mechanisms and potential markers of oxidative stress-related genes in vitiligo and alopecia areata. Skin Res Technol. 30 (8), e70001 (2024).","journal-title":"Skin Res Technol"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"100998","DOI":"10.1016\/j.jpha.2024.100998","type":"journal-article","article-title":"Circulating memory T cells and TCF1 (+) T cells aid in diagnosis and monitor disease activity in vitiligo","volume":"14","author":"Wang","year":"2024","unstructured":"Wang, X. et al. Circulating memory T cells and TCF1 (+) T cells aid in diagnosis and monitor disease activity in vitiligo. J Pharm Anal. 14 (11), 100998 (2024).","journal-title":"J Pharm Anal"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"102580","DOI":"10.1016\/j.coi.2025.102580","type":"journal-article","article-title":"Epigenetic regulation in vitiligo: Mechanisms, challenges, and therapeutic opportunities","volume":"95","author":"Wu","year":"2025","unstructured":"Wu, L., Han, T., Wang, Y., Li, S., Li, C. Epigenetic regulation in vitiligo: Mechanisms, challenges, and therapeutic opportunities. Curr Opin Immunol. 95, 102580 (2025).","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14728222.2023.2193329","type":"journal-article","article-title":"Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection","volume":"27","author":"Xie","year":"2023","unstructured":"Xie, B., Zhu, Y., Shen, Y., Xu, W., Song, X. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection. Expert Opin Ther Targets. 27 (3), 189-206 (2023).","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.6073","type":"journal-article","article-title":"Mif inhibition alleviates vitiligo progression by suppressing CD8 (+) T cell activation and proliferation","volume":"260","author":"Chen","year":"2023","unstructured":"Chen, J. et al. Mif inhibition alleviates vitiligo progression by suppressing CD8 (+) T cell activation and proliferation. J Pathol. 260 (1), 84-96 (2023).","journal-title":"J Pathol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jdermsci.2023.03.004","type":"journal-article","article-title":"Differences in the immune microenvironment between improved and non-improved cases of vitiligo after halo nevus excision","volume":"109","author":"Kano","year":"2023","unstructured":"Kano, S. et al. Differences in the immune microenvironment between improved and non-improved cases of vitiligo after halo nevus excision. J Dermatol Sci. 109 (3), 136-142 (2023).","journal-title":"J Dermatol Sci"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"e2250281","DOI":"10.1002\/eji.202250281","type":"journal-article","article-title":"The ifn-\u03b3-cxcl9\/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment","volume":"54","author":"Liu","year":"2024","unstructured":"Liu, H., Wang, Y., Le, Q., Tong, J., Wang, H. The ifn-\u03b3-cxcl9\/CXCL10-CXCR3 axis in vitiligo: Pathological mechanism and treatment. Eur J Immunol. 54 (4), e2250281 (2024).","journal-title":"Eur J Immunol"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00403-023-02577-7","type":"journal-article","article-title":"Immune checkpoint inhibitor-induced vitiligo in cancer patients: Characterization and management","volume":"315","author":"Lo","year":"2023","unstructured":"Lo, J., Hanania, H. L., Keiser, M. F., Patel, A. B. Immune checkpoint inhibitor-induced vitiligo in cancer patients: Characterization and management. Arch Dermatol Res. 315 (6), 1697-1703 (2023).","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/1346-8138.17698","type":"journal-article","article-title":"Vitiligo associated with type 2 immune inhibitors: Faers analysis and literature review","volume":"52","author":"Lu","year":"2025","unstructured":"Lu, L. et al. Vitiligo associated with type 2 immune inhibitors: Faers analysis and literature review. J Dermatol. 52 (6), 1008-1014 (2025).","journal-title":"J Dermatol"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/1750743X.2024.2377954","type":"journal-article","article-title":"Anti-tumor immunity and vitiligo: From immune-related adverse reactions to protection from cancer","volume":"16","author":"Mazzetto","year":"2024","unstructured":"Mazzetto, R. et al. Anti-tumor immunity and vitiligo: From immune-related adverse reactions to protection from cancer. Immunotherapy. 16 (13), 841-843 (2024).","journal-title":"Immunotherapy"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2024.5136","type":"journal-article","article-title":"Immune checkpoint inhibitor-induced vitiligo-like depigmentation","volume":"161","author":"Starace","year":"2025","unstructured":"Starace, M. et al. Immune checkpoint inhibitor-induced vitiligo-like depigmentation. JAMA Dermatol. 161 (2), 216-218 (2025).","journal-title":"JAMA Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1391186","DOI":"10.3389\/fimmu.2024.1391186","type":"journal-article","article-title":"Circulating immune cells and vitiligo: A bidirectional two-sample mendelian randomization study","volume":"15","author":"Xin","year":"2024","unstructured":"Xin, Y., Yuan, T., Wang, J. Circulating immune cells and vitiligo: A bidirectional two-sample mendelian randomization study. Front Immunol. 15, 1391186 (2024).","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1221260","DOI":"10.3389\/fimmu.2023.1221260","type":"journal-article","article-title":"Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo","volume":"14","author":"Yang","year":"2023","unstructured":"Yang, P. et al. Single-cell transcriptomics reveals peripheral immune responses in non-segmental vitiligo. Front Immunol. 14, 1221260 (2023).","journal-title":"Front Immunol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2022.11.005","type":"journal-article","article-title":"Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial","volume":"88","author":"Ezzedine","year":"2023","unstructured":"Ezzedine, K. et al. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial. J Am Acad Dermatol. 88 (2), 395-403 (2023).","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/bjd\/ljaf041","type":"journal-article","article-title":"Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo","volume":"193","author":"Gay-Mimbrera","year":"2025","unstructured":"Gay-Mimbrera, J. et al. Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo. Br J Dermatol. 193 (1), 115-124 (2025).","journal-title":"Br J Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cytogfr.2024.11.002","type":"journal-article","article-title":"Jak inhibitors in immune regulation and treatment of vitiligo","volume":"80","author":"Liu","year":"2024","unstructured":"Liu, K. et al. Jak inhibitors in immune regulation and treatment of vitiligo. Cytokine Growth Factor Rev. 80, 87-96 (2024).","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref30","volume-title":"Pharmacopoeia of the People\u2019s Republic of China","year":"2020","unstructured":"National Pharmacopoeia Commission. Pharmacopoeia of the People\u2019s Republic of China (2020 Edition, Volume I). Beijing, China Medical Science Press (2020).","type":"book"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/kjm2.12655","type":"journal-article","article-title":"Matrine regulates Th1\/Th2 inflammatory responses by inhibiting the Hsp90\/nf-\u03bab signaling axis to alleviate atopic dermatitis","volume":"39","author":"Huang","year":"2023","unstructured":"Huang, P. et al. Matrine regulates Th1\/Th2 inflammatory responses by inhibiting the Hsp90\/nf-\u03bab signaling axis to alleviate atopic dermatitis. Kaohsiung J Med Sci. 39 (5), 501-510 (2023).","journal-title":"Kaohsiung J Med Sci"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/bjd.17852","type":"journal-article","article-title":"Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis","volume":"181","author":"Shi","year":"2019","unstructured":"Shi, H. J. et al. Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis. Br J Dermatol. 181 (5), 1028-1037 (2019).","journal-title":"Br J Dermatol"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/jdv.19450","type":"journal-article","article-title":"Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international vitiligo task force-part 2: Specific treatment recommendations","volume":"37","author":"Seneschal","year":"2023","unstructured":"Seneschal, J. et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international vitiligo task force-part 2: Specific treatment recommendations. J Eur Acad Dermatol Venereol. 37 (11), 2185-2195 (2023).","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5021\/ad.24.038","type":"journal-article","article-title":"Up-and-coming drugs for the treatment of vitiligo","volume":"36","author":"Seong","year":"2024","unstructured":"Seong, S. H., Oh, S. H. Up-and-coming drugs for the treatment of vitiligo. Ann Dermatol. 36 (4), 197-208 (2024).","journal-title":"Ann Dermatol"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"103841","DOI":"10.1016\/j.autrev.2025.103841","type":"journal-article","article-title":"Genetic and immune dysregulation in vitiligo: Insights into autoimmune mechanisms and disease pathogenesis","volume":"24","author":"Upadhya","year":"2025","unstructured":"Upadhya, S., Andrade, M. J., Shukla, V., Rao, R., Satyamoorthy, K. Genetic and immune dysregulation in vitiligo: Insights into autoimmune mechanisms and disease pathogenesis. Autoimmun Rev. 24 (8), 103841 (2025).","journal-title":"Autoimmun Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1631074","DOI":"10.3389\/fimmu.2025.1631074","type":"journal-article","article-title":"Innate immune activation in vitiligo: Mechanisms and pathophysiological implications","volume":"16","author":"Wang","year":"2025","unstructured":"Wang, Y. et al. Innate immune activation in vitiligo: Mechanisms and pathophysiological implications. Front Immunol. 16, 1631074 (2025).","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"101766","DOI":"10.1016\/j.trim.2022.101766","type":"journal-article","article-title":"Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm","volume":"76","author":"Zhang","year":"2023","unstructured":"Zhang, M. et al. Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm. Transpl Immunol. 76, 101766 (2023).","journal-title":"Transpl Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1164124","DOI":"10.3389\/fimmu.2023.1164124","type":"journal-article","article-title":"Mitophagy and immune infiltration in vitiligo: Evidence from bioinformatics analysis","volume":"14","author":"Luo","year":"2023","unstructured":"Luo, L., Zhu, J., Guo, Y., Li, C. Mitophagy and immune infiltration in vitiligo: Evidence from bioinformatics analysis. Front Immunol. 14, 1164124 (2023).","journal-title":"Front Immunol"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"e1810","DOI":"10.1002\/ctm2.1810","type":"journal-article","article-title":"Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies","volume":"14","author":"Sant'anna-Silva","year":"2024","unstructured":"Sant'anna-Silva, A. C. B. et al. Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategies. Clin Transl Med. 14 (8), e1810 (2024).","journal-title":"Clin Transl Med"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/12034754231168839","type":"journal-article","article-title":"Alopecia areata: An updated review for 2023","volume":"27","author":"Sibbald","year":"2023","unstructured":"Sibbald, C. Alopecia areata: An updated review for 2023. J Cutan Med Surg. 27 (3), 241-259 (2023).","journal-title":"J Cutan Med Surg"},{"issue":"18","key":"ref41","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.3390\/ijms26189233","type":"journal-article","article-title":"Advances in psoriasis research: Decoding immune circuits and developing novel therapies","volume":"26","author":"Wang","year":"2025","unstructured":"Wang, L. et al. Advances in psoriasis research: Decoding immune circuits and developing novel therapies. Int J Mol Sci. 26 (18), 9233 (2025).","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/70371\/therapeutic-efficacy-308-nm-excimer-laser-combined-with-matrine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:16:49Z","timestamp":1792588609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70371\/therapeutic-efficacy-308-nm-excimer-laser-combined-with-matrine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":41,"journal-issue":{"issue":"229","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70371","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}